In lung carcinoma mice models, it has been reported that low expression levels of MPHOSPH8 are linked to sensitization to anti-PD-1/CTLA-4 therapies [58], implying a feasible association of this epigenetic regulator and the suppression of the immune evasion. This evidence concerns the gene MPHOSPH8 and lung carcinoma.